<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR7">
 <label>7.</label>
 <mixed-citation publication-type="other">Eron JJ, Clotet B, Durant J, et al. Safety and Ef fi cacy of Dolutegravir in treatment-experienced subjects with Raltegravir-resistant HIV type 1 infection : 24-week results of the VIKING study. J Infect Dis. 2013;207. 10.1093/infdis/jis750.</mixed-citation>
</ref>
